Dietary Supplement Listing Act of 2026
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
This bill, Dietary Supplement Listing Act of 2026, changes federal law or congressional policy affecting health care providers and patients. The main policy domain is Healthcare, Environment, Agriculture.
Who Benefits and How
health care providers and patients may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.
Who Bears the Burden and How
federal implementing agencies, health care providers and patients may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.
Key Provisions
- Section S1: 1. Short title This Act may be cited as the Dietary Supplement Listing Act of 2026.
- Section ida7f2ffa4159b4ed79abf4831a3473c6f: 2. Regulation of dietary supplements Chapter IV of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 341 et seq.) is amended by adding after section 403C of...
- Section id33eb8d58c2d14cbc92e34bc8e7bc6bdf: 403D. Dietary supplement listing requirement Beginning on the date specified in subsection (b)(4), each dietary supplement marketed in the United States shall...
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
This bill, Dietary Supplement Listing Act of 2026, changes federal law or congressional policy affecting health care providers and patients.
Key Policy Areas
Healthcare, Environment, Agriculture
Primary Purpose
This bill, Dietary Supplement Listing Act of 2026, changes federal law or congressional policy affecting health care providers and patients.
Policy Domains
Whole bill
Identified Gains
- health care providers and patients
Identified Costs
- federal implementing agencies
- health care providers and patients
Legislative Progress
In CommitteeRead twice and referred to the Committee on Health, Education, …
Introduced in Senate
Mr. Durbin introduced the following bill; which was read twice …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "the_secretary"
- → The Secretary identified in the operative section
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology